Compile Data Set for Download or QSAR
Report error Found 190 of ph data with Target = 'Coagulation factor VII'
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31462(substituted biphenyl derivative, 36b)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31468(substituted biphenyl derivative, 36h)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31488(substituted biphenyl derivative, 36ab)
Affinity DataIC50: 9nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31486(substituted biphenyl derivative, 36z)
Affinity DataIC50: 10nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31487(substituted biphenyl derivative, 36aa)
Affinity DataIC50: 10nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31470(substituted biphenyl derivative, 36j)
Affinity DataIC50: 11nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31474(substituted biphenyl derivative, 36n)
Affinity DataIC50: 12nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31467(substituted biphenyl derivative, 36g)
Affinity DataIC50: 13nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31483(substituted biphenyl derivative, 36w)
Affinity DataIC50: 21nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31466(substituted biphenyl derivative, 36f)
Affinity DataIC50: 25nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31475(substituted biphenyl derivative, 36o)
Affinity DataIC50: 29nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31461(substituted biphenyl derivative, 24)
Affinity DataIC50: 30nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31469(substituted biphenyl derivative, 36i)
Affinity DataIC50: 34nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31464(substituted biphenyl derivative, 36d)
Affinity DataIC50: 42nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31471(substituted biphenyl derivative, 36k)
Affinity DataIC50: 45nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14497(N-{4-[Amino(imino)methyl]benzyl}-2-[6-(3,5-diamino...)
Affinity DataIC50: 52nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31473(substituted biphenyl derivative, 36m)
Affinity DataIC50: 52nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31480(substituted biphenyl derivative, 36t)
Affinity DataIC50: 60nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31460(substituted biphenyl derivative, 36a)
Affinity DataIC50: 67nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31465(substituted biphenyl derivative, 36e)
Affinity DataIC50: 92nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31463(substituted biphenyl derivative, 36c)
Affinity DataIC50: 97nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31482(substituted biphenyl derivative, 36v)
Affinity DataIC50: 98nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14495(3-amino-5-[1-({[(4-carbamimidoylphenyl)methyl]carb...)
Affinity DataIC50: 118nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31459(CHEMBL224485 | substituted biphenyl derivative, 21)
Affinity DataIC50: 120nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31472(substituted biphenyl derivative, 36l)
Affinity DataIC50: 130nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14514(CHEMBL78053 | (2R)-N-[(1S)-1-{[(2S)-5-carbamimidam...)
Affinity DataIC50: 200nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31484(substituted biphenyl derivative, 36x)
Affinity DataIC50: 231nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31476(substituted biphenyl derivative, 36p)
Affinity DataIC50: 320nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14597(2-[3-Amino-3-fluoro-4-(isopropylamino)-1,1-bipheny...)
Affinity DataIC50: 340nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14499(N-[(4-carbamimidoylphenyl)methyl]-2-{2-oxo-6-pheny...)
Affinity DataIC50: 340nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14596(2-[6-(3-aminophenyl)-3-(benzylamino)-2-fluoropheny...)
Affinity DataIC50: 500nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31477(substituted biphenyl derivative, 36q)
Affinity DataIC50: 500nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31485(substituted biphenyl derivative, 36y)
Affinity DataIC50: 546nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14498(CHEMBL75084 | N-[(4-carbamimidoylphenyl)methyl]-2-...)
Affinity DataIC50: 630nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14510(2-[3-(benzylamino)-5-chloro-2-oxo-6-phenyl-1,2-dih...)
Affinity DataIC50: 770nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31478(substituted biphenyl derivative, 36r)
Affinity DataIC50: 926nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31481(substituted biphenyl derivative, 36u)
Affinity DataIC50: 1.22E+3nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14501(N-[(6-carbamimidoylpyridin-3-yl)methyl]-2-{2-oxo-6...)
Affinity DataIC50: 1.40E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM31479(substituted biphenyl derivative, 36s)
Affinity DataIC50: 1.61E+3nMpH: 7.2 T: 2°CAssay Description:TF-FVIIa assay reactions were performed in a mixture containing FVIIa , lapidated tissue factor, in an assay buffer in the presence of test compounds...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/13/2009
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14601(N-{4-[Amino(imino)methyl]benzyl}-2-[3-hydroxy-4-(i...)
Affinity DataIC50: 2.50E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14600(N-[(4-carbamimidoylphenyl)methyl]-2-{2-hydroxy-6-p...)
Affinity DataIC50: 2.70E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14602(N-[(4-carbamimidoylphenyl)methyl]-2-[3,6-dioxo-2-p...)
Affinity DataIC50: 2.80E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14595(N-{4-[Amino(imino)methyl]benzyl}-2-{3-fluoro-4-[(2...)
Affinity DataIC50: 3.98E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14512(N-[(4-carbamimidoylphenyl)methyl]-2-{5-chloro-2-ox...)
Affinity DataIC50: 4.10E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14513(N-[(4-carbamimidoylphenyl)methyl]-2-[5-chloro-2-ox...)
Affinity DataIC50: 6.30E+3nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14509(N-[(4-carbamimidoylphenyl)methyl]-2-[5-chloro-2-ox...)
Affinity DataIC50: 1.12E+4nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14511(N-[(4-carbamimidoylphenyl)methyl]-2-{5-chloro-2-ox...)
Affinity DataIC50: 1.26E+4nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14599(N-[(4-carbamimidoylphenyl)methyl]-2-[2-methoxy-6-p...)
Affinity DataIC50: 1.47E+4nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14594(N-[(4-carbamimidoylphenyl)methyl]-2-{2,6-difluoro-...)
Affinity DataIC50: 1.64E+4nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
TargetCoagulation factor VII(Human)
Biocryst Pharmaceuticals

LigandPNGBDBM14500(N-[(5-carbamimidoylpyridin-2-yl)methyl]-2-{2-oxo-6...)
Affinity DataIC50: 1.67E+4nMpH: 8.0 T: 2°CAssay Description:Recombinant human Factor VIIa and soluble tissue factor were added to a 96-well assay plate containing substrate and inhibitor in reaction buffer. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/2/2007
Entry Details Article
PubMed
Displayed 1 to 50 (of 190 total ) | Next | Last >>
Jump to: